nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR2A—phrenic nerve—thymus cancer	0.0394	0.161	CbGeAlD
Mirtazapine—Breast feeding—Octreotide—thymus cancer	0.0231	0.0306	CcSEcCtD
Mirtazapine—HTR7—pulmonary artery—thymus cancer	0.0229	0.0935	CbGeAlD
Mirtazapine—Goitre—Octreotide—thymus cancer	0.0226	0.0299	CcSEcCtD
Mirtazapine—HTR7—vein—thymus cancer	0.0209	0.0851	CbGeAlD
Mirtazapine—Intraocular pressure increased—Octreotide—thymus cancer	0.0183	0.0243	CcSEcCtD
Mirtazapine—Ulcerative stomatitis—Octreotide—thymus cancer	0.0175	0.0232	CcSEcCtD
Mirtazapine—HTR2A—pulmonary artery—thymus cancer	0.0143	0.0583	CbGeAlD
Mirtazapine—Cholecystitis—Octreotide—thymus cancer	0.014	0.0186	CcSEcCtD
Mirtazapine—HTR2A—vein—thymus cancer	0.013	0.053	CbGeAlD
Mirtazapine—Hypothyroidism—Octreotide—thymus cancer	0.0126	0.0167	CcSEcCtD
Mirtazapine—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0118	0.0157	CcSEcCtD
Mirtazapine—Paranoia—Octreotide—thymus cancer	0.0118	0.0157	CcSEcCtD
Mirtazapine—Intestinal obstruction—Octreotide—thymus cancer	0.0118	0.0157	CcSEcCtD
Mirtazapine—HRH3—hematopoietic system—thymus cancer	0.0114	0.0463	CbGeAlD
Mirtazapine—Metrorrhagia—Octreotide—thymus cancer	0.0113	0.015	CcSEcCtD
Mirtazapine—Throat sore—Octreotide—thymus cancer	0.0112	0.0148	CcSEcCtD
Mirtazapine—Oropharyngeal discomfort—Octreotide—thymus cancer	0.0111	0.0147	CcSEcCtD
Mirtazapine—Herpes zoster—Octreotide—thymus cancer	0.0107	0.0142	CcSEcCtD
Mirtazapine—Coagulopathy—Octreotide—thymus cancer	0.0104	0.0137	CcSEcCtD
Mirtazapine—Otitis media—Octreotide—thymus cancer	0.0104	0.0137	CcSEcCtD
Mirtazapine—Nephrolithiasis—Octreotide—thymus cancer	0.01	0.0133	CcSEcCtD
Mirtazapine—Stinging—Octreotide—thymus cancer	0.00996	0.0132	CcSEcCtD
Mirtazapine—Petechiae—Octreotide—thymus cancer	0.00981	0.013	CcSEcCtD
Mirtazapine—Acne—Octreotide—thymus cancer	0.00959	0.0127	CcSEcCtD
Mirtazapine—Breast pain—Octreotide—thymus cancer	0.00925	0.0123	CcSEcCtD
Mirtazapine—Amenorrhoea—Octreotide—thymus cancer	0.00918	0.0122	CcSEcCtD
Mirtazapine—Cellulitis—Octreotide—thymus cancer	0.00887	0.0118	CcSEcCtD
Mirtazapine—Arthropathy—Octreotide—thymus cancer	0.00887	0.0118	CcSEcCtD
Mirtazapine—Oropharyngeal pain—Octreotide—thymus cancer	0.00887	0.0118	CcSEcCtD
Mirtazapine—Herpes simplex—Octreotide—thymus cancer	0.00875	0.0116	CcSEcCtD
Mirtazapine—Muscle twitching—Octreotide—thymus cancer	0.00822	0.0109	CcSEcCtD
Mirtazapine—Vaginal inflammation—Octreotide—thymus cancer	0.00807	0.0107	CcSEcCtD
Mirtazapine—Eructation—Octreotide—thymus cancer	0.00793	0.0105	CcSEcCtD
Mirtazapine—Cystitis noninfective—Octreotide—thymus cancer	0.00788	0.0104	CcSEcCtD
Mirtazapine—Cystitis—Octreotide—thymus cancer	0.00779	0.0103	CcSEcCtD
Mirtazapine—Candida infection—Octreotide—thymus cancer	0.0077	0.0102	CcSEcCtD
Mirtazapine—Vaginal infection—Octreotide—thymus cancer	0.00762	0.0101	CcSEcCtD
Mirtazapine—Mouth ulceration—Octreotide—thymus cancer	0.00729	0.00967	CcSEcCtD
Mirtazapine—Urine output increased—Octreotide—thymus cancer	0.00729	0.00967	CcSEcCtD
Mirtazapine—Bladder pain—Octreotide—thymus cancer	0.00729	0.00967	CcSEcCtD
Mirtazapine—Hyperkinesia—Octreotide—thymus cancer	0.00704	0.00932	CcSEcCtD
Mirtazapine—Phlebitis—Octreotide—thymus cancer	0.0068	0.00901	CcSEcCtD
Mirtazapine—Diabetes mellitus—Octreotide—thymus cancer	0.00673	0.00892	CcSEcCtD
Mirtazapine—Polyuria—Octreotide—thymus cancer	0.00667	0.00884	CcSEcCtD
Mirtazapine—Gastroenteritis—Octreotide—thymus cancer	0.00661	0.00876	CcSEcCtD
Mirtazapine—Deafness—Octreotide—thymus cancer	0.00655	0.00868	CcSEcCtD
Mirtazapine—Amnesia—Octreotide—thymus cancer	0.00623	0.00826	CcSEcCtD
Mirtazapine—Arthritis—Octreotide—thymus cancer	0.00603	0.00799	CcSEcCtD
Mirtazapine—Osteoarthritis—Octreotide—thymus cancer	0.00586	0.00776	CcSEcCtD
Mirtazapine—Psychotic disorder—Octreotide—thymus cancer	0.00572	0.00758	CcSEcCtD
Mirtazapine—HTR3A—hematopoietic system—thymus cancer	0.00545	0.0222	CbGeAlD
Mirtazapine—Dehydration—Octreotide—thymus cancer	0.00545	0.00722	CcSEcCtD
Mirtazapine—Dry skin—Octreotide—thymus cancer	0.00537	0.00711	CcSEcCtD
Mirtazapine—Gastritis—Octreotide—thymus cancer	0.00518	0.00687	CcSEcCtD
Mirtazapine—Muscular weakness—Octreotide—thymus cancer	0.00516	0.00685	CcSEcCtD
Mirtazapine—Abdominal distension—Octreotide—thymus cancer	0.0051	0.00675	CcSEcCtD
Mirtazapine—Influenza—Octreotide—thymus cancer	0.00506	0.00671	CcSEcCtD
Mirtazapine—Asthma—Octreotide—thymus cancer	0.00506	0.00671	CcSEcCtD
Mirtazapine—Pancreatitis—Octreotide—thymus cancer	0.00496	0.00658	CcSEcCtD
Mirtazapine—Sweating increased—Octreotide—thymus cancer	0.00493	0.00653	CcSEcCtD
Mirtazapine—Bronchitis—Octreotide—thymus cancer	0.00487	0.00645	CcSEcCtD
Mirtazapine—HTR7—neck—thymus cancer	0.00474	0.0193	CbGeAlD
Mirtazapine—Dysuria—Octreotide—thymus cancer	0.00473	0.00627	CcSEcCtD
Mirtazapine—Pollakiuria—Octreotide—thymus cancer	0.00468	0.0062	CcSEcCtD
Mirtazapine—Weight increased—Octreotide—thymus cancer	0.00461	0.0061	CcSEcCtD
Mirtazapine—Weight decreased—Octreotide—thymus cancer	0.00458	0.00607	CcSEcCtD
Mirtazapine—Pneumonia—Octreotide—thymus cancer	0.00454	0.00602	CcSEcCtD
Mirtazapine—SLC6A3—hematopoietic system—thymus cancer	0.00454	0.0185	CbGeAlD
Mirtazapine—Drowsiness—Octreotide—thymus cancer	0.00451	0.00598	CcSEcCtD
Mirtazapine—Jaundice—Octreotide—thymus cancer	0.0044	0.00583	CcSEcCtD
Mirtazapine—Urinary tract infection—Octreotide—thymus cancer	0.00439	0.00581	CcSEcCtD
Mirtazapine—Conjunctivitis—Octreotide—thymus cancer	0.00439	0.00581	CcSEcCtD
Mirtazapine—Haematuria—Octreotide—thymus cancer	0.0043	0.0057	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Octreotide—thymus cancer	0.00427	0.00566	CcSEcCtD
Mirtazapine—Epistaxis—Octreotide—thymus cancer	0.00426	0.00564	CcSEcCtD
Mirtazapine—Sinusitis—Octreotide—thymus cancer	0.00423	0.00561	CcSEcCtD
Mirtazapine—SLC6A4—hematopoietic system—thymus cancer	0.00416	0.0169	CbGeAlD
Mirtazapine—Bradycardia—Octreotide—thymus cancer	0.00412	0.00547	CcSEcCtD
Mirtazapine—Rhinitis—Octreotide—thymus cancer	0.00406	0.00538	CcSEcCtD
Mirtazapine—Hepatitis—Octreotide—thymus cancer	0.00405	0.00537	CcSEcCtD
Mirtazapine—Hypoaesthesia—Octreotide—thymus cancer	0.00403	0.00534	CcSEcCtD
Mirtazapine—Pharyngitis—Octreotide—thymus cancer	0.00402	0.00533	CcSEcCtD
Mirtazapine—Oedema peripheral—Octreotide—thymus cancer	0.00399	0.00529	CcSEcCtD
Mirtazapine—Tinnitus—Octreotide—thymus cancer	0.00378	0.00501	CcSEcCtD
Mirtazapine—Cardiac disorder—Octreotide—thymus cancer	0.00376	0.00498	CcSEcCtD
Mirtazapine—HTR1A—hematopoietic system—thymus cancer	0.00369	0.015	CbGeAlD
Mirtazapine—Arrhythmia—Octreotide—thymus cancer	0.00362	0.0048	CcSEcCtD
Mirtazapine—Alopecia—Octreotide—thymus cancer	0.00358	0.00474	CcSEcCtD
Mirtazapine—Mental disorder—Octreotide—thymus cancer	0.00355	0.0047	CcSEcCtD
Mirtazapine—HTR7—hematopoietic system—thymus cancer	0.00353	0.0144	CbGeAlD
Mirtazapine—Malnutrition—Octreotide—thymus cancer	0.00353	0.00467	CcSEcCtD
Mirtazapine—Flatulence—Octreotide—thymus cancer	0.00348	0.00461	CcSEcCtD
Mirtazapine—Tension—Octreotide—thymus cancer	0.00346	0.00459	CcSEcCtD
Mirtazapine—Nervousness—Octreotide—thymus cancer	0.00343	0.00454	CcSEcCtD
Mirtazapine—Back pain—Octreotide—thymus cancer	0.00341	0.00452	CcSEcCtD
Mirtazapine—ADRA1A—hematopoietic system—thymus cancer	0.0034	0.0139	CbGeAlD
Mirtazapine—Tremor—Octreotide—thymus cancer	0.0033	0.00438	CcSEcCtD
Mirtazapine—Ill-defined disorder—Octreotide—thymus cancer	0.00327	0.00434	CcSEcCtD
Mirtazapine—ADRB1—cardiac atrium—thymus cancer	0.00327	0.0133	CbGeAlD
Mirtazapine—Anaemia—Octreotide—thymus cancer	0.00326	0.00432	CcSEcCtD
Mirtazapine—Agitation—Octreotide—thymus cancer	0.00324	0.0043	CcSEcCtD
Mirtazapine—HTR7—epithelium—thymus cancer	0.00323	0.0131	CbGeAlD
Mirtazapine—Malaise—Octreotide—thymus cancer	0.00318	0.00422	CcSEcCtD
Mirtazapine—Vertigo—Octreotide—thymus cancer	0.00317	0.0042	CcSEcCtD
Mirtazapine—HTR3A—lung—thymus cancer	0.00317	0.0129	CbGeAlD
Mirtazapine—Syncope—Octreotide—thymus cancer	0.00316	0.00419	CcSEcCtD
Mirtazapine—Palpitations—Octreotide—thymus cancer	0.00312	0.00413	CcSEcCtD
Mirtazapine—ADRA1A—epithelium—thymus cancer	0.00311	0.0127	CbGeAlD
Mirtazapine—Loss of consciousness—Octreotide—thymus cancer	0.0031	0.00411	CcSEcCtD
Mirtazapine—Cough—Octreotide—thymus cancer	0.00308	0.00408	CcSEcCtD
Mirtazapine—Convulsion—Octreotide—thymus cancer	0.00306	0.00405	CcSEcCtD
Mirtazapine—Hypertension—Octreotide—thymus cancer	0.00304	0.00404	CcSEcCtD
Mirtazapine—CYP2C8—hematopoietic system—thymus cancer	0.00301	0.0123	CbGeAlD
Mirtazapine—Arthralgia—Octreotide—thymus cancer	0.003	0.00398	CcSEcCtD
Mirtazapine—Chest pain—Octreotide—thymus cancer	0.003	0.00398	CcSEcCtD
Mirtazapine—Myalgia—Octreotide—thymus cancer	0.003	0.00398	CcSEcCtD
Mirtazapine—Anxiety—Octreotide—thymus cancer	0.00299	0.00397	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00298	0.00395	CcSEcCtD
Mirtazapine—Discomfort—Octreotide—thymus cancer	0.00297	0.00393	CcSEcCtD
Mirtazapine—HTR2A—neck—thymus cancer	0.00296	0.012	CbGeAlD
Mirtazapine—Dry mouth—Octreotide—thymus cancer	0.00294	0.00389	CcSEcCtD
Mirtazapine—Oedema—Octreotide—thymus cancer	0.00288	0.00381	CcSEcCtD
Mirtazapine—Infection—Octreotide—thymus cancer	0.00286	0.00379	CcSEcCtD
Mirtazapine—Shock—Octreotide—thymus cancer	0.00283	0.00375	CcSEcCtD
Mirtazapine—Nervous system disorder—Octreotide—thymus cancer	0.00282	0.00374	CcSEcCtD
Mirtazapine—Thrombocytopenia—Octreotide—thymus cancer	0.00282	0.00373	CcSEcCtD
Mirtazapine—CYP1A2—hematopoietic system—thymus cancer	0.00281	0.0115	CbGeAlD
Mirtazapine—Tachycardia—Octreotide—thymus cancer	0.00281	0.00372	CcSEcCtD
Mirtazapine—Skin disorder—Octreotide—thymus cancer	0.0028	0.00371	CcSEcCtD
Mirtazapine—Hyperhidrosis—Octreotide—thymus cancer	0.00278	0.00369	CcSEcCtD
Mirtazapine—Anorexia—Octreotide—thymus cancer	0.00274	0.00364	CcSEcCtD
Mirtazapine—CYP2C9—hematopoietic system—thymus cancer	0.00267	0.0109	CbGeAlD
Mirtazapine—SLC6A3—lung—thymus cancer	0.00264	0.0107	CbGeAlD
Mirtazapine—HTR2B—thyroid gland—thymus cancer	0.00264	0.0107	CbGeAlD
Mirtazapine—HRH1—hematopoietic system—thymus cancer	0.00263	0.0107	CbGeAlD
Mirtazapine—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00262	0.00348	CcSEcCtD
Mirtazapine—Insomnia—Octreotide—thymus cancer	0.0026	0.00345	CcSEcCtD
Mirtazapine—ADRA2A—hematopoietic system—thymus cancer	0.00259	0.0105	CbGeAlD
Mirtazapine—Paraesthesia—Octreotide—thymus cancer	0.00258	0.00343	CcSEcCtD
Mirtazapine—Dyspnoea—Octreotide—thymus cancer	0.00257	0.0034	CcSEcCtD
Mirtazapine—Somnolence—Octreotide—thymus cancer	0.00256	0.00339	CcSEcCtD
Mirtazapine—Dyspepsia—Octreotide—thymus cancer	0.00253	0.00336	CcSEcCtD
Mirtazapine—Decreased appetite—Octreotide—thymus cancer	0.0025	0.00332	CcSEcCtD
Mirtazapine—ADRB1—lung—thymus cancer	0.0025	0.0102	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Octreotide—thymus cancer	0.00248	0.00329	CcSEcCtD
Mirtazapine—Fatigue—Octreotide—thymus cancer	0.00248	0.00329	CcSEcCtD
Mirtazapine—DRD2—pituitary gland—thymus cancer	0.00247	0.0101	CbGeAlD
Mirtazapine—ADRA2C—cardiac atrium—thymus cancer	0.00246	0.01	CbGeAlD
Mirtazapine—Constipation—Octreotide—thymus cancer	0.00246	0.00326	CcSEcCtD
Mirtazapine—Pain—Octreotide—thymus cancer	0.00246	0.00326	CcSEcCtD
Mirtazapine—SLC6A4—lung—thymus cancer	0.00242	0.00984	CbGeAlD
Mirtazapine—HRH1—epithelium—thymus cancer	0.00241	0.00981	CbGeAlD
Mirtazapine—ADRA2C—pituitary gland—thymus cancer	0.00241	0.0098	CbGeAlD
Mirtazapine—ADRA1A—lymphoid tissue—thymus cancer	0.0024	0.00976	CbGeAlD
Mirtazapine—HTR2B—lung—thymus cancer	0.00239	0.00975	CbGeAlD
Mirtazapine—Feeling abnormal—Octreotide—thymus cancer	0.00237	0.00314	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Octreotide—thymus cancer	0.00235	0.00312	CcSEcCtD
Mirtazapine—Urticaria—Octreotide—thymus cancer	0.00229	0.00303	CcSEcCtD
Mirtazapine—Body temperature increased—Octreotide—thymus cancer	0.00228	0.00302	CcSEcCtD
Mirtazapine—Abdominal pain—Octreotide—thymus cancer	0.00228	0.00302	CcSEcCtD
Mirtazapine—CYP2C8—pituitary gland—thymus cancer	0.00223	0.00909	CbGeAlD
Mirtazapine—HTR2A—hematopoietic system—thymus cancer	0.0022	0.00896	CbGeAlD
Mirtazapine—SLC6A2—lung—thymus cancer	0.00213	0.00866	CbGeAlD
Mirtazapine—Hypersensitivity—Octreotide—thymus cancer	0.00212	0.00281	CcSEcCtD
Mirtazapine—Asthenia—Octreotide—thymus cancer	0.00207	0.00274	CcSEcCtD
Mirtazapine—HTR7—lung—thymus cancer	0.00205	0.00835	CbGeAlD
Mirtazapine—CYP3A4—hematopoietic system—thymus cancer	0.00204	0.0083	CbGeAlD
Mirtazapine—Pruritus—Octreotide—thymus cancer	0.00204	0.0027	CcSEcCtD
Mirtazapine—HTR2A—epithelium—thymus cancer	0.00201	0.00819	CbGeAlD
Mirtazapine—CYP2D6—hematopoietic system—thymus cancer	0.002	0.00817	CbGeAlD
Mirtazapine—Diarrhoea—Octreotide—thymus cancer	0.00197	0.00261	CcSEcCtD
Mirtazapine—ADRA2A—cardiac atrium—thymus cancer	0.00197	0.008	CbGeAlD
Mirtazapine—DRD2—lung—thymus cancer	0.00194	0.00789	CbGeAlD
Mirtazapine—ADRA2A—pituitary gland—thymus cancer	0.00192	0.00782	CbGeAlD
Mirtazapine—Dizziness—Octreotide—thymus cancer	0.0019	0.00252	CcSEcCtD
Mirtazapine—ADRA2C—lung—thymus cancer	0.00188	0.00767	CbGeAlD
Mirtazapine—Vomiting—Octreotide—thymus cancer	0.00183	0.00243	CcSEcCtD
Mirtazapine—Rash—Octreotide—thymus cancer	0.00181	0.00241	CcSEcCtD
Mirtazapine—Dermatitis—Octreotide—thymus cancer	0.00181	0.0024	CcSEcCtD
Mirtazapine—Headache—Octreotide—thymus cancer	0.0018	0.00239	CcSEcCtD
Mirtazapine—CYP1A2—thyroid gland—thymus cancer	0.0018	0.00733	CbGeAlD
Mirtazapine—Nausea—Octreotide—thymus cancer	0.00171	0.00227	CcSEcCtD
Mirtazapine—ADRA2A—thyroid gland—thymus cancer	0.00165	0.00674	CbGeAlD
Mirtazapine—HTR2B—lymph node—thymus cancer	0.00164	0.00667	CbGeAlD
Mirtazapine—CYP1A2—lung—thymus cancer	0.00163	0.00666	CbGeAlD
Mirtazapine—HTR2A—pituitary gland—thymus cancer	0.00163	0.00665	CbGeAlD
Mirtazapine—HRH1—lung—thymus cancer	0.00153	0.00623	CbGeAlD
Mirtazapine—ADRA2A—lung—thymus cancer	0.0015	0.00612	CbGeAlD
Mirtazapine—SLC6A2—lymph node—thymus cancer	0.00145	0.00592	CbGeAlD
Mirtazapine—ADRA2C—lymph node—thymus cancer	0.00129	0.00525	CbGeAlD
Mirtazapine—HTR2A—lung—thymus cancer	0.00128	0.00521	CbGeAlD
Mirtazapine—HRH1—lymph node—thymus cancer	0.00105	0.00426	CbGeAlD
Mirtazapine—ADRA2A—lymph node—thymus cancer	0.00103	0.00419	CbGeAlD
